Critical Care Alert – February 1, 2009
February 1, 2009
View Issues
-
MRSA Ventilator-associated Pneumonia: Vancomycin or Linezolid?
Methicillin-resistant staphylococcus aureus (MRSA) is a common cause of ventilator-associated pneumonia (VAP). -
Benefits of a Dedicated ICU Clinical Pharmacist
In 2004, the authors of this study conducted a survey of U.S. hospitals with ICUs to assess the prevalence and use of dedicated ICU clinical pharmacists. -
Mobilizing Patients in the ICU Is Safe and Cost-effective
This study compared outcomes in 330 patients who were managed with mobility therapy (n = 165) vs usual care (n = 165) in a medical ICU. Patients were prospectively enrolled within 48 hours of intubation and 72 hours of ICU admission. -
Straining to Predict Fluid Responsiveness
Despite the prominent role that volume challenges play in the management of hypotensive patients, we lack simple, reliable methods to determine which patients will respond to such challenges. -
Rapid Response Team Did Not Reduce Hospital-Wide Codes or Mortality
Chan and Aassociates performed a prospective before-and-after cohort study of the effects of implementing a rapid response team (RRT) in a 404-bed tertiary-care academic hospital in Kansas City, MO. -
Pharmacology Watch: How Best to Control Hypertension?
In this issue: Drug combinations for hypertension; tenecteplase for out-of-hospital cardiac arrest; CAM most commonly used for back, neck, and arthritis pain; FDA Actions. -
Clinical Briefs in Primary Care supplement